期刊
VACCINE
卷 27, 期 52, 页码 7299-7303出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2009.08.023
关键词
Memory B cells; Plasmodium falciparum; Malaria; Toll-like receptor 9
资金
- National institute of Allergy and Infectious Diseases, National Institutes of Health
Antibodies play a key role in controlling blood stage malaria infections, and an effective blood stage malaria vaccine will likely require that it induce vaccine-specific memory B cells (MBCs). Our previous studies showed that the addition of the TLR9 agonist CpG to Plasmodium falciparum protein subunit vaccines greatly increased their efficacy in inducing MBCs in nonimmune U.S. volunteers. Here we show that in contrast the same CpG-containing malaria vaccine did not enhance the acquisition of MBCs in semi-immune adults living in Mali. Understanding the molecular basis of this apparent refractoriness to TLR9 agonist will be of significant interest in vaccine design. Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据